Discontinuation report TRANSDERM-NITRO 0.4

Last updated on 2020-07-10 History
Report ID 119964
Drug Identification Number 00852384
Brand name TRANSDERM-NITRO 0.4
Common or Proper name Transderm Nitro 0.4
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) NITROGLYCERIN
Strength(s) 0.4MG
Dosage form(s) PATCH (EXTENDED RELEASE)
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 30
ATC code C01DA
ATC description VASODILATORS USED IN CARDIAC DISEASES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-10-31
Actual discontinuation date
Remaining supply date 2021-04-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments The 0,6 mg will still be available until stock depletion or shelf life expiration (Aug 2021
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-07-10 French Compare
v1 2020-07-10 English Compare